PHIN-214 is under clinical development by PharmaIN and currently in Phase I for ...
Want to stay on top of the science and politics driving biotech today? Sign up t...
Top of the morning to you. And a fine one it is. Lots of sunshine and clear blue...
Do celebrity vaccine endorsements like Travis Kelce’s actually change behavior?
The government will force hospitals to be better about publishing the prices the...
House Democrats, citing recent STAT investigations, want the Biden administratio...
More than 10 million people were disenrolled from Medicaid over the past six mon...
Want to stay on top of the science and politics driving biotech today? Sign up t...
And so, another working week will soon draw to a close. Not a moment too soon, y...
Most of the formularies run by some of the largest health plans in the U.S. gene...
Colorado’s Prescription Drug Affordability Board could end up limiting access to...
A patient still deals with memory loss after brain surgery: "I can't live in the...
Healthy people should get medical insurance, but not necessarily because it’s in...
Medicare officials are moving forward with a plan to claw back money from certai...
A key Senate panel announced it will consider policies to regulate pharmacy midd...
Vascular device maker Inari Medical announced plans to buy LimFlow, a company se...
